Market Tracker

01/16 1:05pm ET

Array Biopharma Inc (NASDAQ:ARRY)

10.87
Delayed Data
As of Jan 13
 +0.76 / +7.52%
Today’s Change
2.38
Today|||52-Week Range
11.22
+23.66%
Year-to-Date
After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next
Jan 10 / MotleyFool.com - Paid Partner Content
Why Array BioPharma Inc Stock Surged 108.3% in 2016
Jan 09 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close10.11
Today’s open10.17
Day’s range10.17 - 11.22
Volume11,135,358
Average volume (3 months)5,916,965
Market cap$1.8B
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-18.63%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp+0.65+1.18%
AGIOAgios Pharmaceutical...-0.06-0.14%
PRTAProthena Corporation...-0.01-0.02%
TBPHTheravance Biopharma...-0.06-0.18%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 7, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts